Activation of latent protease function of Pro-HK2, but not Pro-PSA, involves autoprocessing

被引:30
作者
Denmeade, SR
Lövgren, J
Khan, SR
Lilja, H
Isaacs, JT
机构
[1] Johns Hopkins Oncol Ctr, Baltimore, MD 21231 USA
[2] Lund Univ, Dept Lab Med, Div Clin Chem, Univ Hosp, Malmo, Sweden
[3] Univ Turku, Dept Biotechnol, Turku, Finland
关键词
auto-processing; prostate cancer; prostate-specific antigen (PSA); human glandular kallikrein 2 (hK2); propeptide;
D O I
10.1002/pros.1088
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND. Human glandular kallikrein 2 (hK2) and prostate-specific antigen (PSA) are members of an extensive kallikrein family of proteases. Both proteases are secreted as zymogens or proenzymes containing a seven amino acid propeptide that must be proteolytically removed for enzymatic activation. The physiological proteases that activate pro-hK2 and pro-PSA are not known. METHODS. The pro-hK2 peptide sequence is Val-Pro-Leu-Ile-Gln-Ser-Arg (VPLIQSR). For PSA, the amino acid sequence of the propeptide is Ala-Pro-Leu-Ile-Leu-Ser-Arg (APLILSR). Fluorescent substrates were made by coupling these peptide sequences to 7-amino-3-methylcoumarin (AMC). The hydrolysis of the VPLIQSR-AMC and APLILSR-AMC substrates by hK2, PSA, and a panel of purified proteases was determined. RESULTS. HK2 readily cleaved the pro-hK2 peptide substrate VPLIQSR-AMC with a rate of hydrolysis that was similar to 8-fold higher than an equimolar amount of purified trypsin. HK2 also had the highest hydrolysis rate from among a group of other trypsin-like proteases. In contrast, neither hK2 nor PSA was able to appreciably cleave the pro-PSA substrate APLILSR-AMC. The pro-PSA substrate was most readily hydrolyzed by urokinase and trypsin. CONCLUSIONS. HK2 can hydrolyze the pro-hK2 substrate suggesting that maturation of pro-hK2 to enzymatically active hK2 involves autoprocessing, As expected, PSA, a chymotrypsin-like protease, was unable to hydrolyze either of the propeptide substrates. Therefore, it is unlikely that PSA can auto-process its own enzymatic function. HK2 has trypsin-like specificity but was unable to hydrolyze the pro-PSA substrate. These results raise the possibility that an additional processing protease may be required to fully process PSA to an enzymatically active form. (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:122 / 126
页数:5
相关论文
共 28 条
[1]   THE CHYMOTRYPSIN-LIKE ACTIVITY OF HUMAN PROSTATE-SPECIFIC ANTIGEN, GAMMA-SEMINOPROTEIN [J].
AKIYAMA, K ;
NAKAMURA, T ;
IWANAGA, S ;
HARA, M .
FEBS LETTERS, 1987, 225 (1-2) :168-172
[2]   Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (hK2) in serum [J].
Becker, C ;
Piironen, T ;
Pettersson, K ;
Björk, T ;
Wojno, KJ ;
Oesterling, JE ;
Lilja, H .
JOURNAL OF UROLOGY, 2000, 163 (01) :311-316
[3]   ENZYMATIC-ACTIVITY OF PROSTATE-SPECIFIC ANTIGEN AND ITS REACTIONS WITH EXTRACELLULAR SERINE PROTEINASE-INHIBITORS [J].
CHRISTENSSON, A ;
LAURELL, CB ;
LILJA, H .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1990, 194 (03) :755-763
[4]   Human glandular kallikrein 2 expression in prostate adenocarcinoma and lymph node metastases [J].
Darson, MF ;
Pacelli, A ;
Roche, P ;
Ritttenhouse, HG ;
Wolfert, RL ;
Saeid, MS ;
Young, CYF ;
Klee, GG ;
Tindall, DJ ;
Bostwick, DG .
UROLOGY, 1999, 53 (05) :939-944
[5]   Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: A novel prostate cancer marker [J].
Darson, MF ;
Pacelli, A ;
Roche, P ;
Rittenhouse, HG ;
Wolfert, RL ;
Young, CYF ;
Klee, GG ;
Tindall, DJ ;
Bostwick, DG .
UROLOGY, 1997, 49 (06) :857-862
[6]  
Denmeade SR, 1997, CANCER RES, V57, P4924
[7]  
Denmeade SR, 1998, CANCER RES, V58, P2537
[8]   Isolation of prostatic kallikrein hK2, also known as hGK-1, in human seminal plasma [J].
Deperthes, D ;
Chapdelaine, P ;
Tremblay, RR ;
Brunet, C ;
Berton, J ;
Hebert, J ;
Lazure, C ;
Dube, JY .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1995, 1245 (03) :311-316
[9]  
Diamandis EP, 2000, CLIN CHEM, V46, P1855
[10]   The new human kallikrein gene family: Implications in carcinogenesis [J].
Diamandis, EP ;
Yousef, GM ;
Luo, LY ;
Magklara, A ;
Obiezu, CV .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2000, 11 (02) :54-60